Eukaryotic initiation factor 2 beta modulator (Bristol Meyer Squibb/Evotec)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameEukaryotic initiation factor 2 beta modulator (Bristol Meyer Squibb/Evotec)
Drug Alias NameeIF2B Activator
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEukaryotic translation initiation factor 2B modulators
TargetsEukaryotic translation initiation factor 2B
Therapy Area/IndicationsAlzheimer DiseaseNervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesEvotec (UK) LtdBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A